Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/04/2010US20100280109 Lipid compounds for use in cosmetic products, as food supplement or as a medicament
11/04/2010US20100280108 Antitumoral Compounds
11/04/2010US20100280107 Treating benign prostate hyperplasia with sarms
11/04/2010US20100280106 Oral composition to reduce cold symptoms and duration of same
11/04/2010US20100280104 Methods and kits for diagnosis and treatment of cell-cell junction related disorders
11/04/2010US20100280103 Methods and compositions for acid phosphatase-1 gene inhibition
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280101 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
11/04/2010US20100280100 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010US20100280099 Combination Treatment For The Treatment of Hepatitis C Virus Infection
11/04/2010US20100280098 Receptor targeted oligonucleotides
11/04/2010US20100280097 Compositions comprising hif-1 alpha sirna and methods of use thereof
11/04/2010US20100280096 Treatment of influenza
11/04/2010US20100280095 Therapeutic agent for wounds and screening method for the same
11/04/2010US20100280094 Compositions and methods to treat muscular & cardiovascular disorders
11/04/2010US20100280093 Process for the preparation enantiomerically pure salts of n-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine
11/04/2010US20100280092 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/04/2010US20100280091 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disbustituted pyran derivatives
11/04/2010US20100280090 Tape preparation comprising etodolac in ionic liquid form
11/04/2010US20100280089 Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
11/04/2010US20100280087 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280084 Cyp1B1 Genotype
11/04/2010US20100280083 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/04/2010US20100280082 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators
11/04/2010US20100280081 Anti-inflammatory agents as virostatic compounds
11/04/2010US20100280080 Medicaments
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280078 1-(Azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
11/04/2010US20100280077 Process for Preparation of Stable Amorphous R-Lansoprazole
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280071 Benzimidazoles which have activity at m1 receptor and their uses in medicine
11/04/2010US20100280070 Novel tetrahydroquinolines as aromatase inhibitors
11/04/2010US20100280069 Controlled release local anesthetic for post dental surgery and method of use
11/04/2010US20100280067 Inhibitors of acetyl-coa carboxylase
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280064 Pharmaceutical composition having improved storage stability
11/04/2010US20100280063 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
11/04/2010US20100280062 (e)-n--methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
11/04/2010US20100280061 Novel analgesic that binds filamin a
11/04/2010US20100280060 Methods of screening and compositions for life span modulators
11/04/2010US20100280059 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100280058 Spirocyclic heterocyclic derivatives and methods of their use
11/04/2010US20100280057 Novel analgesic that binds filamin a
11/04/2010US20100280056 Identification of subjects likely to benefit from statin therapy
11/04/2010US20100280055 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
11/04/2010US20100280054 Multicyclic amino acid derivatives and methods of their use
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280051 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010US20100280050 Piperidinylamino-Thieno[2,3-D] Pyrimidine Compounds for Treating Fibrosis
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280047 Salts of active ingredients with polymeric counter-ions
11/04/2010US20100280046 Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280044 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100280043 Pyrazolopyridines as kinase inhibitors
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100280041 Rhokinase-dependent inhibition activity on pulmonary artery endothelium dysfunction, medial wall thickness and vascular obstruction of pulmodil and pulmodil-1
11/04/2010US20100280040 Synthesis and pharmacokinetic activities of pulmodil and pulmodil-1, two chlorophenylpiperazine salt derivatives
11/04/2010US20100280039 Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
11/04/2010US20100280038 Methods of treatment of chronic pain using eszopiclone
11/04/2010US20100280037 Crystalline form of a dihydropteridione derivative
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280035 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280033 Pyrazole Derivatives
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280031 Lipid formulation of apoptosis promoter
11/04/2010US20100280030 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280025 Equilibrative nucleoside transporter ent1 inhibitors
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280023 Thiazole derivatives
11/04/2010US20100280022 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
11/04/2010US20100280021 Pyridopyrimidine protein tyrosine phosphatase inhibitors
11/04/2010US20100280020 Isoxazoles
11/04/2010US20100280019 Isoxazoles
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280017 Combination of Selected Analgesics and Cox-II Inhibitors
11/04/2010US20100280016 Pyrazoline compounds
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100280011 Dual mechanism inhibitors for the treatment of disease
11/04/2010US20100280010 Chemical compounds
11/04/2010US20100280009 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/04/2010US20100280008 Aurora kinase modulators and method of use
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280006 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
1 ... 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 ... 7860